A detailed history of Abel Hall, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Abel Hall, LLC holds 2,107 shares of BSX stock, worth $216,367. This represents 0.08% of its overall portfolio holdings.

Number of Shares
2,107
Previous 3,511 39.99%
Holding current value
$216,367
Previous $377 Million 45.46%
% of portfolio
0.08%
Previous 0.17%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 17, 2025

SELL
$97.03 - $108.14 $136,230 - $151,828
-1,404 Reduced 39.99%
2,107 $206 Million
Q2 2025

Jul 23, 2025

BUY
$89.7 - $107.41 $11,571 - $13,855
129 Added 3.81%
3,511 $377 Million
Q1 2025

May 06, 2025

BUY
$89.38 - $106.18 $302,283 - $359,100
3,382 New
3,382 $341 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $147B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Abel Hall, LLC Portfolio

Follow Abel Hall, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abel Hall, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Abel Hall, LLC with notifications on news.